Targeting accelerated kidney ageing in chronic kidney disease: from senolytics to Klotho therapeutics
Chronic kidney disease (CKD) is accompanied by cellular changes that resemble accelerated ageing, including persistent senescence and loss of α-Klotho. Experimental studies connect these processes, but their causal relationship in human CKD remains uncertain. This Perspective evaluates senolytics, senomorphics and α-Klotho-directed therapies as distinct but potentially complementary strategies, and proposes phenotype-led development centred on renal target engagement, biomarkers and staged testing of monotherapy, combination and sequential approaches.
Authors
- Javier Donate-Correa
Institutions
- Hospital Universitario Nuestra Señora de Candelaria (ES)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-11318782/v1
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- preprint
Funders
- Fundación Mapfre
- Instituto de Salud Carlos III